During the recent session, Karyopharm Therapeutics Inc (NASDAQ:KPTI)’s traded shares were 0.51 million, with the beta value of the company hitting 0.29. At the last
In the last trading session, 64571.0 shares of the Karyopharm Therapeutics Inc (NASDAQ:KPTI) were traded, and its beta was 0.29. Most recently the company’s share
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne